Keracnyl PP Anti-Blemish Soothing Cream

The single biggest reason acne treatments fail isn't that they don't work. It's that patients stop using them. Dermatologists who've spent years prescribing tretinoin, adapalene, and benzoyl peroxide know the pattern: the patient starts enthusiastically, experiences the adjustment-phase dryness and irritation that comes with every effective acne active, decides the treatment is making things worse, and quits before the clearing phase can even begin. The clinical literature is remarkably consistent on this — adherence drops off a cliff at the three-to-six-week mark for exactly this reason. The actives work. The patients don't stay on them.

Keracnyl PP was built as Pierre Fabre's answer to that specific problem, and understanding that origin is the key to knowing whether this cream is right for you. This is not a standalone acne treatment. It will not replace your adapalene or your benzoyl peroxide or your salicylic acid wash. What it will do is calm the barrier damage those treatments create, reduce the irritation that makes patients quit, and provide mild anti-inflammatory and mild anti-bacterial support through ingredients that don't add to the existing irritation load. It's a companion product, positioned in the French pharmacy acne protocol specifically for use alongside stronger actives during the adjustment and maintenance phases.

The formula is built around niacinamide at what appears to be a meaningful concentration — around 4% in most of the published information about the product. Niacinamide at that level has a real body of clinical research behind it for acne-prone skin: it reduces sebum production, calms the inflammatory component of active blemishes, supports barrier repair, and has a mild brightening effect on post-inflammatory hyperpigmentation. On top of the niacinamide base sits the Keracnyl line's signature botanical: Myrtacine, a patented extract of Myrtus communis (common myrtle) leaf that Pierre Fabre's research team characterized as having anti-biofilm activity against C. acnes. The biofilm angle is interesting because most acne research focuses on killing the bacteria directly (which is what benzoyl peroxide does), while the biofilm that protects them is left intact. Disrupting that biofilm, even modestly, makes the bacteria more vulnerable to other treatments. Add zinc PCA for its sebum-regulating and anti-inflammatory effect, bisabolol for chamomile-derived anti-inflammatory support, and allantoin as a gentle skin protectant, and you have a formula that targets the inflammatory-and-bacterial components of acne without adding to the drying damage that patients are already struggling with from their primary treatments.

The texture is a genuinely well-executed light cream-gel: white, smooth, absorbing in about forty-five seconds without leaving a film. It has a matte finish that layers cleanly under sunscreen and makeup, which matters for an acne-prone demographic that's often juggling coverage products over active blemishes. It's fragrance-free, alcohol-free, oil-free, and fungal-acne safe — a combination that rules out most of the common irritation sources for acne patients and makes it appropriate for the fungal folliculitis subset who otherwise have a hard time finding compatible products.

In use, the calming effect shows up fast. On skin that's been hammered by adapalene or benzoyl peroxide for a few weeks, applying this cream produces visible reduction in redness and a meaningful softening of the tight, parched feel within the first application. Over the following week, the cumulative effect is that you can tolerate your primary acne actives at higher frequency and strength than you could without it. That's the real benefit — not that the cream itself clears your acne, but that it enables the products that do to actually get used consistently. Published patient adherence data on combined-treatment regimens consistently shows better outcomes when a tolerable buffering agent is part of the routine.

The limitations are worth naming clearly. The 30 ml tube is small, and with twice-daily use on the full face, you'll go through it in six to eight weeks. There's no larger size option. For patients expecting a standalone acne product, the subtle mechanism will be disappointing — you need to go in understanding what this cream is for. It's not fragranced, which some users reflexively interpret as clinical or boring, though for acne-prone skin that's actually a feature rather than a bug. And availability in the US is limited to specialty retailers and direct-to-consumer import, though Ductray's US distribution has been improving.

For patients who are struggling with irritation from their primary acne treatments, for adolescents or adults starting adapalene and needing a tolerability buffer, for anyone managing the overlap of acne-prone and sensitive skin, this is one of the easier recommendations in the category. It plays the role it was designed for — quiet, reliable, supportive — and lets the harder-working actives in your routine do their jobs.

Formula

The Science

Niacinamide's role in acne-prone skin has one of the more robust evidence bases in topical dermatology. Published work in the Journal of the American Academy of Dermatology and other clinical journals has demonstrated that topical niacinamide at 4-5% produces measurable reductions in sebum excretion rates, calms inflammatory acne lesions, and supports barrier function over 4-12 week application windows. In comparative studies, niacinamide has been shown to produce acne improvement comparable to topical clindamycin in some patient populations, with substantially better tolerability.

Myrtacine — Pierre Fabre's patented Myrtus communis leaf extract — has a more recent but interesting evidence base. Published work characterizing the extract has shown anti-biofilm activity against C. acnes, which matters because biofilms protect acne-associated bacteria from both the host immune response and topical anti-bacterial treatments. The practical implication is that disrupting the biofilm can make the bacteria more vulnerable to benzoyl peroxide and antibiotic treatments, potentially enabling lower effective doses.

Zinc's evidence base in acne goes back decades. Topical and oral zinc have both been studied in acne vulgaris, with the topical form showing mild anti-inflammatory and sebum-regulating effects. The PCA ester form used in this cream is a humectant-conjugated version that also contributes to skin hydration.

The strategic point of this formula is that it targets the inflammatory, bacterial, and barrier-damage components of acne without relying on mechanisms (keratolysis, comedone loosening) that are already being addressed by the retinoid or benzoyl peroxide in the patient's primary treatment. That non-overlapping activity is what makes it effective as a companion cream rather than as another exfoliating active added to an already-irritated routine.

Dermatologist Perspective

Dermatologists treating acne-prone patients frequently incorporate soothing companion creams into comprehensive regimens, particularly for patients who've shown early signs of intolerance to their primary actives. This product is commonly suggested by European dermatologists as the daily moisturizer layer in adapalene and tretinoin protocols, and as a mid-day calming application for patients dealing with inflammatory flares. Board-certified dermatologists familiar with the Keracnyl line typically position it as the tolerability enabler in a two-to-three-product acne routine — the cream that keeps the patient on the primary treatment long enough for the primary treatment to work. Dermatologists also appreciate that it's fragrance-free and fungal-acne safe, which makes it appropriate for patients managing the overlap between acne and Malassezia folliculitis.

Guidance

The Keracnyl PP variant was developed as Pierre Fabre's response to a common clinical problem: patients on aggressive acne treatments (adapalene, benzoyl peroxide, tretinoin) often abandon their regimen because of irritation and barrier damage. Rather than a standalone acne spot treatment, the PP version was built as a companion cream — calming, buffering, and mildly anti-bacterial — to help patients stay on their primary treatments long enough to see results.

About Ducray Legacy Brand (20+ years)

Ducray has been formulating dermatological products under Pierre Fabre since 1930, with the Keracnyl line dedicated to acne-prone skin for over a decade. The PP (Post-Procedure / Protective) variant is widely recommended by French dermatologists as a companion product to more aggressive acne treatments.

Brand founded: 1930 · Product launched: 2013

Myth vs. Reality

Myth

Soothing creams are a waste of time for acne — you need actives that dry things out.

Reality

Published dermatology literature shows that barrier damage and irritation are among the top reasons patients stop using effective acne treatments. A soothing companion cream that keeps the barrier intact can meaningfully improve long-term outcomes by enabling adherence to the actives that actually clear the acne.

FAQ

Common Praise

"calms redness from active acne treatments"

"lightweight on oily skin"

"works well layered under sunscreen"

"reduces barrier damage from retinoids"

Common Complaints

"small 30 ml tube"

"not a standalone acne treatment"

"subtle rather than dramatic effect"

"hard to find outside European pharmacies"

Notable Endorsements

French pharmacy acne protocol staplerecommended as adapalene companion cream

Appears In

best niacinamide creams for acne best soothing creams for acne prone skin best french pharmacy acne products best ducray products best retinoid buffering creams

Related Conditions

acne oiliness blackheads post procedure compromised skin barrier

Related Ingredients

niacinamide myrtle extract zinc bisabolol